利波卡林-2,可溶性转移林受体,以及在轻度功能障碍期间贫血中的红素
Chung Hyun Nahm1, Moon Hee Lee2, Tatsuyoshi Fujii3
1Department of Laboratory Medicine, College of Medicine, Inha University, Incheon, Republic of Korea.
升高的利波卡林-2 (LCN2) 与轻度功能障碍 (MRD) 中的贫血有关. 较高的LCN2水平与减少的网细胞生产和增加的贫血患病率相关,这表明LCN2
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 血液学 血液学 血液学
- 生物化学 生物化学
背景情况:
- 轻度功能障碍 (MRD) 是与糖尿病和炎症相关的常见并发症.
- 在高血压患者中,MRD是心血管疾病的已知风险因素.
- 卡林-2 (LCN2) 在调节铁代谢和促进MRD贫血中的作用仍未得到充分研究.
研究的目的:
- 调查LCN2,溶性转激素受体 (sTfR),红色素 (EPO) 和MRD中的网细胞生产之间的关系.
- 确定LCN2水平与MRD患者贫血患病率之间的关联.
主要方法:
- 分析了235名患有MRD的受试者的队列.
- 测量包括LCN2,sTfR,EPO和铁含量.
- 计算了网细胞成熟度指数 (RMI) 和更正的LCN2 (cLCN2).
主要成果:
- 升高的LCN2与较高的sTfR,较低的RMI,较低的血红蛋白水平和较高的贫血患病率有关.
- 贫血患者的LCN2和cLCN2水平显著上升.
- 升高的LCN2与sTfR呈正相关性,与RMI呈负相关性,使贫血风险增加了1.3倍.
结论:
- 利波卡林-2的升高可能会导致轻度功能障碍的贫血发展.
- 这一贡献似乎与铁的可用性受限和抑制的网细胞生产有关.
- 在MRD患者中,LCN2作为潜在的贫血风险生物标志物.
更多相关视频
08:53Author Spotlight: Advancing Erythropoiesis Research - A Simplified Pipeline for Assessing Hematopoietic Stem Cell Function in Myelodysplastic Syndromes
Published on: January 10, 2025
06:40Mouse Fetal Liver Culture System to Dissect Target Gene Functions at the Early and Late Stages of Terminal Erythropoiesis
Published on: September 9, 2014
相关概念视频
Chronic Kidney Disease II: Clinical Manifestations
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Chronic Kidney Disease III: Interprofessional Care
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Factors Affecting Erythropoiesis
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Erythropoiesis
